Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Receptor agonists/antagonists

Receptor Agonist Antagonist Effects Gene on Chromosome... [Pg.172]

Localization of Receptors Agonist Antagonist Receptor Type... [Pg.102]

Zhang S, Qin C, Safe SH. Flavonoids as aryl hydrocarbon receptor agonists/ antagonists Effects of structure and cell context. Environ Health Perspect 2003 111 1877-82. [Pg.93]

Thrombin inhibitors and thrombin receptor agonists/antagonists... [Pg.271]

THROMBIN RECEPTOR AGONISTS/ANTAGONISTS Thrombin receptor mechanisms... [Pg.280]

Abstract Benzimidazole is a biologically important scaffold which displays important biological activities. Recent progress in the synthesis and bioactivity of benzimidazoles is reviewed. New synthetic procedures, including microwave-assisted synthesis, solid phase synthesis, natural product synthesis, and synthesis of bisbenzimidazoles are briefly described. Functionalization and cyclization reactions of benzimidazoles lead to a wide variety of novel benzimidazole structures. Selected bioactivity, such as anti-infective, anti-inflammatory, antitumor and receptor agonist/antagonist activities are presented. [Pg.87]

Fig. 2. Distribution of twelve large target-specific groups of pharmaceutical agents within the Kohonen map (a) G-protein-coupled receptors (GPCR) agonists/antagonists (5,432 compounds) (b) matrix metalloproteinase inhibitors (120 compounds) (c) tyrosine kinase inhibitors (175 compounds) (d) caspase inhibitors (50 compounds) (e) NMDA receptor agonists/antagonists (150 compounds) (f) potassium channel blockers/activators (302 compounds) ... Fig. 2. Distribution of twelve large target-specific groups of pharmaceutical agents within the Kohonen map (a) G-protein-coupled receptors (GPCR) agonists/antagonists (5,432 compounds) (b) matrix metalloproteinase inhibitors (120 compounds) (c) tyrosine kinase inhibitors (175 compounds) (d) caspase inhibitors (50 compounds) (e) NMDA receptor agonists/antagonists (150 compounds) (f) potassium channel blockers/activators (302 compounds) ...
Rosati, R.L. and Da Silva, J.P. (1998) Discovery and predinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphfhalene. Journal of Medicinal Chemistry, 41, 2928—2931. [Pg.20]

Dezocine, an opiate receptor agonist-antagonist, possessing an analgesic property (5 to 20 mg IM q. 3 to 6 hours), is used in the management of moderate to severe pain. [Pg.196]


See other pages where Receptor agonists/antagonists is mentioned: [Pg.191]    [Pg.42]    [Pg.88]    [Pg.517]    [Pg.301]    [Pg.238]    [Pg.332]    [Pg.148]    [Pg.148]    [Pg.209]    [Pg.156]    [Pg.256]    [Pg.56]    [Pg.64]    [Pg.128]    [Pg.812]    [Pg.234]    [Pg.191]    [Pg.87]    [Pg.112]    [Pg.35]    [Pg.46]    [Pg.561]    [Pg.598]    [Pg.598]    [Pg.640]    [Pg.19]    [Pg.110]    [Pg.19]    [Pg.761]   
See also in sourсe #XX -- [ Pg.112 ]




SEARCH



Receptor agonists

© 2024 chempedia.info